Maruyama, Yuko
Ikeda, Yoko https://orcid.org/0000-0003-3131-9156
Yoshii, Kengo
Mori, Kazuhiko
Ueno, Morio
Kinoshita, Shigeru
Sotozono, Chie
Article History
Received: 31 December 2023
Accepted: 29 May 2024
First Online: 11 July 2024
Declarations
:
: This study was presented at 10th World Glaucoma Congress; June 28th – July 1st 2023; Rome, Italy.
: Y. Maruyama, Payment or honoraria for lectures (Senju, Kowa, Otsuka); Y. Ikeda, Payment or honoraria for lectures (Otsuka, Senju, Santen, Kowa, Alcon, Viatris, Rohto Nitten), Patents planned, issued or pending (Santen); K. Yoshii, None; K. Mori, Royalty (Ocular Instruments), Consulting fees (Santen), Payment or honoraria for lectures (Santen, Senju, Otsuka, Kowa, Glaukos, Inami, Topcon), Patents (Santen), Equipment rent (Alcon), Software rent (Logic & Design); M. Ueno, Honorarium for lecture (Kowa); S. Kinoshita, Grants to the author’s institution (Otsuka, Senju, Santen), Royalties or licenses (Aurion Biotechnologies), Consulting fees (Otsuka, Senju, Santen, Kowa), Payment or honoraria for lectures (Otsuka, Senju, Santen, Kowa); C. Sotozono, Grants to the author’s institution (Santen, Sun Contact Lens, CorneaGen), Payment or honoraria for lectures (Otsuka, Senju, Santen, Kowa, Nitto Medic).